Patents by Inventor Stephanie Garcia

Stephanie Garcia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DEVICE FOR REPRODUCING A HEARTBEAT PATTERN TO MEMORIALIZE A LOVED ONE
    Publication number: 20230393660
    Abstract: Devices, systems, and methods for reproducing or simulating a heartbeat pattern in accordance with aspects of the present disclosure. In particular aspects, a device is configured to reproduce a tactile, auditory, and/or visual output representing a heartbeat pattern of a loved one. A user may perceive, during operation, the reproduced heartbeat pattern reproduced by the device. For example, the user may touch the device (e.g., may wrap a hand around the device, may pressed the device against any part of the user's body, etc.), the device may be activated (e.g., by the user's touch) and may reproduce an output (e.g., tactile, auditory, and/or visual) causing the user to perceive the heartbeat pattern. The heartbeat pattern may be one stored in the device, an external device and provided to the device via a link, or generated by the device dynamically during operation.
    Type: Application
    Filed: May 11, 2023
    Publication date: December 7, 2023
    Inventors: Juan Jesus Vasquez, Juan Daniel Vasquez, Alec Voldis Vasquez, David Adrian Vasquez, Tatjana Vasquez, Stephanie Garcia
  • Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof
    Patent number: 11697678
    Abstract: The invention features soluble fibroblast growth factor receptor 3 (sFGFR3) polypeptides. The invention also features methods of using sFGFR3 polypeptides to treat skeletal growth regardation disorders, such as achondroplasia.
    Type: Grant
    Filed: April 20, 2021
    Date of Patent: July 11, 2023
    Assignees: Pfizer Inc., INSERM (Institut National de la Santé et de la Recherche Médicale), Université Côte d'Azur
    Inventors: Elvire Gouze, Stéphanie Garcia
  • SOLUBLE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (SFGFR3) POLYPEPTIDES AND USES THEREOF
    Publication number: 20210309718
    Abstract: The invention features soluble fibroblast growth factor receptor 3 (sFGFR3) polypeptides. The invention also features methods of using sFGFR3 polypeptides to treat skeletal growth regardation disorders, such as achondroplasia.
    Type: Application
    Filed: April 20, 2021
    Publication date: October 7, 2021
    Applicants: Pfizer Inc., INSERM (Institut National de la Santé et de la Recherche Médicale), Université Côte d'Azur
    Inventors: Elvire Gouze, Stéphanie Garcia
  • Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof
    Patent number: 11021528
    Abstract: The invention features soluble fibroblast growth factor receptor 3 (sFGFR3) polypeptides. The invention also features methods of using sFGFR3 polypeptides to treat skeletal growth retardation disorders, such as achondroplasia.
    Type: Grant
    Filed: May 20, 2019
    Date of Patent: June 1, 2021
    Assignees: INSERM (Institut National de la Santé et de la Recherche Médicale, Pfizer Inc., Université Côte d'Azur
    Inventors: Elvire Gouze, Stéphanie Garcia
  • SOLUBLE FGFR3 DECOYS FOR TREATING SKELETAL GROWTH DISORDERS
    Publication number: 20210009657
    Abstract: The invention features soluble FGF decoy polypeptides and fusion polypeptides comprising an FGF decoy polypeptide linked to a heterologous polypeptide, such as an aggrecan binding protein. Both soluble FGF decoy polypeptides and fusion polypeptides can be used to prevent or treat skeletal disorders, such as achondroplasia.
    Type: Application
    Filed: February 20, 2020
    Publication date: January 14, 2021
    Applicants: Pfizer Inc., INSERM (Institut National de la Sante et de la Recherche Medicale), Université Côte d'Azur
    Inventors: Elvire Gouze, Stéphanie Garcia
  • TREATMENT OF ABNORMAL VISCERAL FAT DEPOSITION USING SOLUBLE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (SFGFR3) POLYPEPTIDES
    Publication number: 20200297799
    Abstract: The invention features methods of using SFGFR3 polypeptides to treat abnormal visceral fat deposition and the conditions associated with abnormal visceral fat deposition.
    Type: Application
    Filed: September 20, 2018
    Publication date: September 24, 2020
    Applicants: Pfizer Inc., Université Côte d'Azur, INSERM (Institut National de la Santé et de la Recherche Médicale), Centre National de la Recherche Scientifique
    Inventors: Elvire Gouze, Stéphanie Garcia
  • SOLUBLE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (SFGFR3) POLYPEPTIDES AND USES THEREOF
    Publication number: 20200190162
    Abstract: The invention features soluble fibroblast growth factor receptor 3 (sFGFR3) polypeptides. The invention also features methods of using sFGFR3 polypeptides to treat skeletal growth retardation disorders, such as achondroplasia.
    Type: Application
    Filed: May 20, 2019
    Publication date: June 18, 2020
    Inventors: Elvire GOUZE, Stéphanie GARCIA
  • PLANNING AND ORGANIZING SYSTEM
    Publication number: 20200079135
    Abstract: A comprehensive, all-in-one planning calendar and personal organizer structured and arranged to permit a user to be better organized, and to keep all their daily essentials from iPad® to smartphone to business-cards, files, flash drives, pens, petty cash and more in one easily carried, instantly accessible device.
    Type: Application
    Filed: September 12, 2018
    Publication date: March 12, 2020
    Inventor: Stephanie Garcia
  • Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof
    Patent number: 10294289
    Abstract: The invention features soluble fibroblast growth factor receptor 3 (sFGFR3) polypeptides. The invention also features methods of using sFGFR3 polypeptides to treat skeletal growth retardation disorders, such as achondroplasia.
    Type: Grant
    Filed: April 2, 2018
    Date of Patent: May 21, 2019
    Assignees: Therachon SAS, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE NICE SOPHIA ANTIPOLIS
    Inventors: Elvire Gouze, Stéphanie Garcia
  • SOLUBLE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (SFGFR3) POLYPEPTIDES AND USES THEREOF
    Publication number: 20180230197
    Abstract: The invention features soluble fibroblast growth factor receptor 3 (sFGFR3) polypeptides. The invention also features methods of using sFGFR3 polypeptides to treat skeletal growth retardation disorders, such as achondroplasia.
    Type: Application
    Filed: April 2, 2018
    Publication date: August 16, 2018
    Inventors: Elvire GOUZE, Stéphanie GARCIA
  • SOLUBLE FGFR3 DECOYS FOR TREATING SKELETAL GROWTH DISORDERS
    Publication number: 20180148494
    Abstract: The invention features soluble FGF decoy polypeptides and fusion polypeptides comprising an FGF decoy polypeptide linked to a heterologous polypeptide, such as an aggrecan binding protein. Both soluble FGF decoy polypeptides and fusion polypeptides can be used to prevent or treat skeletal disorders, such as achondroplasia.
    Type: Application
    Filed: January 7, 2016
    Publication date: May 31, 2018
    Applicants: TheAchon, Inserm (Institut National de la Sante et de la Recherche Medicale), Universite Nice Sophia Antipolis
    Inventors: Elvire GOUZE, Stéphanie GARCIA